19.09.2023 • News

MSD Ireland Opens New Site in Dunboyne, Completes Expansion in Carlow

In Ireland, US drugmaker MSD has opened its new facility in Dunboyne, County Meath, and has expanded its Carlow site. MSD says it has invested more than €1 billion at both sites, creating 670 new jobs and increasing the number of employees in Ireland to 3,100. 100 of the newly created positions remain to be filled.

The Carlow facility serves as a filling site for vaccines, biologics, and small molecule drug products. Established in 2008, it was MSD’s first vaccines operation outside of the US.

The Dunboyne facility is MSD's first facility for the commercialization of single-use biologics and plays an important role in the commercialization of important medicines and will significantly reduce the time to market for a drug, the company said.

Sanat Chattopadhyay, executive vice president and president of MSD’s manufacturing division, said: “Our MSD Carlow expansion and new MSD Dunboyne facility are both pivotal components of our global operations. These two facilities will yield substantial enhancements to our manufacturing capabilities, enabling our global network to better address the always-evolving demand for vaccines and medicines worldwide.”

Marie Martin, site lead at MSD Carlow, added: “Today’s announcement is a testament to the talent, hard work, and commitment of our team in Carlow and our colleagues across Ireland and internationally, who truly take our mission to Invent for Life to the next level every single day. Over the past 15 years, we are proud to have built a world-class center of excellence for MSD in Carlow.”

“Today marks a significant milestone in MSD Dunboyne’s journey as we officially open our new, state-of-the-art facility. At MSD, our focus is always on the patient and by harnessing the expertise and synergy between our exceptional research and manufacturing teams, we are not only shortening the timeline for drug development but also creating healthier, happier futures for patients worldwide,” added Eva Gallagher, site lead at MSD Dunboyne.

MSDs site in Dunboyne, Ireland. Source: MSD
MSD's site in Dunboyne, Ireland. Source: MSD

Company

Logo:

Merck & Co

126 East Lincoln Avenue
07065 Rahway
US

Company contact







Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Leading Transformation
The Path to Sustainable Growth

Leading Transformation

As Executive Vice President of International Chemicals since early 2024, Antje Gerber has been steering Sasol through a pivotal reset—focused on resilience, innovation, and bold sustainability goals.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.